₹614.35
+1.15 (+0.19%)
As of 28 Aug 2026, Lincoln Pharmaceuticals Ltd share price is ₹614.35. The stock opened at ₹614.35 and had closed at ₹613.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹439.95 and a high of ₹770.00. In terms of performance, Lincoln Pharmaceuticals Ltd share price has increased by 0.46% over the past six months and has increased by 13.90% over the last year.
LINCOLN Charts
Lincoln Pharmaceuticals Ltd Overview
Market cap₹1,231 Crs
Volume1,186
Prev. Close₹613.20
Year range₹439.95 - ₹770.00
Total Value₹7,28,619.10
ISININE405C01035
About LINCOLN
Lincoln Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceutical products.
Lincoln Pharmaceuticals Ltd Historical Performance
1 Month Return5.83%
6 Month Return-3.68%
3 Year Return21.65%
3 Month Return-18.99%
1 Year Return13.46%
5 Year Return81.79%
Lincoln Pharmaceuticals Ltd Fundamental Analysis
ROCE(TTM)15.18%
P/E Ratio (TTM)12.76
P/B Ratio1.62
Debt to Equity0.01
ROE11.60%
EPS (TTM)48.15
Dividend Yield0.29%
Book Value378.25
Profit Margin13.89%
Operating Margin12.45%
Lincoln Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 201.54 | 183.08 | 181.47 | 170.59 | 169.34 |
| EBITDA | 51.69 | 20.65 | 38.74 | 32.66 | 39.08 |
| Net Profit | 36.23 | 11.63 | 28.60 | 19.98 | 27.68 |
| EPS | 18.09 | 5.81 | 14.28 | 9.98 | 13.82 |
Lincoln Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 52.69 |
| MACD | 4.21 |
| 20-Day SMA | 604.77 |
Lincoln Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Lincoln Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Lincoln Pharmaceuticals Ltd today is ₹614.35 on NSE and ₹614.35 on BSE.
- The 52-week high of Lincoln Pharmaceuticals Ltd is ₹770.00, while the 52-week low is ₹439.95.
- The current market capitalisation of Lincoln Pharmaceuticals Ltd is approximately ₹1,231 crore.
- The P/E (Price-to-Earnings) ratio of Lincoln Pharmaceuticals Ltd is 14.18. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Lincoln Pharmaceuticals Ltd is 1.74. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Lincoln Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Lincoln Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Lincoln Pharmaceuticals Ltd has delivered a return of approximately 21.65%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Lincoln Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 49.78% promoters, 4.60% FIIs, 0.27% DIIs, and 36.12% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
